Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Liabilities and Shareholders Equity (2023 - 2026)

Cannabis Bioscience International Holdings' Liabilities and Shareholders Equity history spans 4 years, with the latest figure at $1544.0 for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 89.63% to $1544.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $74497.0, a 51.34% decrease, with the full-year FY2025 number at $31880.0, down 44.23% from a year prior.
  • Liabilities and Shareholders Equity hit $1544.0 in Q1 2026 for Cannabis Bioscience International Holdings, down from $22131.0 in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for CBIH hit a ceiling of $101842.0 in Q4 2023 and a floor of $1544.0 in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $42435.4 across 4 years, with a median of $34766.0 in 2024.
  • Biggest five-year swings in Liabilities and Shareholders Equity: surged 31.76% in 2024 and later crashed 89.63% in 2026.
  • Tracing CBIH's Liabilities and Shareholders Equity over 4 years: stood at $101842.0 in 2023, then tumbled by 65.86% to $34766.0 in 2024, then tumbled by 36.34% to $22131.0 in 2025, then plummeted by 93.02% to $1544.0 in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for CBIH at $1544.0 in Q1 2026, $22131.0 in Q4 2025, and $18942.0 in Q3 2025.